Citigroup »

Impact Biomedical shares owned by Citigroup

Quarter-by-quarter ownership of Impact Biomedical (IBO) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Impact Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Impact Biomedical held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Impact Biomedical by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $212 353 0.60

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Impact Biomedical

Geode Capital Management
Vanguard Capital Management
State Street Corporation
Vanguard Fiduciary Trust
BlackRock
Northern Trust
Two Sigma Investments
UBS Group
Vanguard Global Advisers
Mason & Associates
Morgan Stanley
Global Trust Asset Management
Citigroup
FMR
Wells Fargo & Company

View all funds holding Impact Biomedical